1 asset in Hypoactive Sexual Desire Disorder
Therapeutic assets addressing Hypoactive Sexual Desire Disorder, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Flibanserin Hypoactive Sexual Desire Disorder | Memorial Sloan Kettering Cancer Center | P2 | CCC (53) |